innate immunity

AB0040 VEXAS SYNDROME: CLINICAL CHARACTERISTICS, TREATMENT AND OUTCOME EXPERIENCE FROM A SINGLE CENTRE COHORT
A. Lamas, F. Pinto, D. G. Oliveira, M. E. Oliveira, A. R. Gonçalves, F. Santos, R. Santos, L. Regadas, R. Faria

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1246-1247; DOI: 10.1136/annrheumdis-2024-eular.5937
AB0043 COMPARATIVE ANALYSIS OF GSDMD LEVELS IN FMF AND APPENDICITIS: SHARED PYROPTOTIC PATHWAYS IN INFLAMMATORY CONDITIONS
O. C. Kilinc, Y. S. Akdeniz, Z. Taskin, M. Karabulut, A. Kaya, I. M. Bolayirli, G. Can, S. Ugurlu

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1248-1249; DOI: 10.1136/annrheumdis-2024-eular.6255
AB0047 REPLICATION OF THE 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE-INDUCED SKIN PATHERGY TEST IN AN INDEPENDENT COHORT OF PATIENTS WITH BEHÇET DISEASE
R. Deniz, A. Gül

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1250-1251; DOI: 10.1136/annrheumdis-2024-eular.2817
AB0052 HEALTH-RELATED QUALITY OF LIFE IN CHILDREN WITH PFAPA SYNDROME AND BEHCET’S DISEASE
A. Gürel Bedir, S. S. Kilic

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1253; DOI: 10.1136/annrheumdis-2024-eular.656
AB0077 IMMUNOGENICITY AND SAFETY PROSPECTIVE STUDY OF ANTI-SARS-CoV-2 MRNA VACCINATION IN A REAL-LIFE SETTING OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
M. Ferraioli, I. Prevete, M. S. Chimenti, L. De Marco, S. Meschi, D. Mariotti, A. Aiello, V. Vanini, G. Cuzzi, A. Salmi, F. Maggi, D. Goletti, G. D. Sebastiani

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1268-1269; DOI: 10.1136/annrheumdis-2024-eular.2900
POS0829 LONG-TERM PROGNOSTIC VALUE OF INNATE LYMPHOID CELLS IN SYSTEMIC SCLEROSIS: A COMPREHENSIVE 5-YEAR ANALYSIS
A. M. Ramming, C. Schmidkonz, A. Atzinger, M. G. Raimondo, S. Rauber, J. Distler, G. Schett, A. Ramming

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1062; DOI: 10.1136/annrheumdis-2024-eular.4941
POS1007 THE INVOLVEMENT OF THE C5 AND C5AR1 GENES IN THE PATHOGENESIS OF IgAV
J. C. Batista-Liz, V. Calvo-Río, M. Sebastián Mora-Gil, B. Sevilla-Pérez, J. L. Callejas, M. T. Leonardo, A. Peñalba, M. J. Cabero, J. Narváez, L. Martín-Penagos, L. Belmar-Vega, C. Gomez-Fernandez, L. Caminal-Montero, P. Collado, P. Quiroga Colina, E. Vicente-Rabaneda, E. Rubio-Romero, M. León Luque, J. M. Blanco-Madrigal, E. Galíndez-Agirregoikoa, S. Castañeda, R. Blanco, V. Pulito-Cueto, R. López-Mejías

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1068-1069; DOI: 10.1136/annrheumdis-2024-eular.381
POS1008 CHARACTERIZATION OF ALPHA-1 ANTITRYPSIN FUNCTION IN ANCA-ASSOCIATED VASCULITIS
L. Fussner, I. Bilic, C. Mcalear, D. Cuthbertson, J. Cheng, E. Chen, M. Weiller, U. Specks, P. A. Merkel

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1069; DOI: 10.1136/annrheumdis-2024-eular.3636
POS1011 ABNORMALITIES IN CIRCULATING POLYMORPHONUCLEAR CELLS IN ANCA-ASSOCIATED VASCULITIS
L. Iorio, C. Baggio, F. Davanzo, M. Codirenzi, E. Fiorin, F. Oliviero, R. Padoan, A. Doria

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1070-1071; DOI: 10.1136/annrheumdis-2024-eular.5003
POS0551 PHARMACODYNAMIC EFFECTS AND EXPLORATORY EFFICACY OF AFIMETORAN, A TLR7/8 INHIBITOR, IN PATIENTS WITH CUTANEOUS LUPUS ERYTHEMATOSUS
F. Baribaud, J. Saini, S. Ignatenko, K. Chadwick, L. Zhu, H. Y. T. Bach, H. Karabeber, M. Dawes, M. Harrison, L. Carayannopoulos, G. Krishna, F. Hosein

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1110-1111; DOI: 10.1136/annrheumdis-2024-eular.1540

Main menu

innate immunity

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

innate immunity

Pages